DPH.L
Dechra Pharmaceuticals PLC
Price:  
3,866.00 
GBP
Volume:  
6,886,170.00
United Kingdom | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DPH.L WACC - Weighted Average Cost of Capital

The WACC of Dechra Pharmaceuticals PLC (DPH.L) is 7.9%.

The Cost of Equity of Dechra Pharmaceuticals PLC (DPH.L) is 8.40%.
The Cost of Debt of Dechra Pharmaceuticals PLC (DPH.L) is 4.60%.

Range Selected
Cost of equity 6.90% - 9.90% 8.40%
Tax rate 24.00% - 24.90% 24.45%
Cost of debt 4.00% - 5.20% 4.60%
WACC 6.5% - 9.2% 7.9%
WACC

DPH.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.49 0.7
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.90%
Tax rate 24.00% 24.90%
Debt/Equity ratio 0.11 0.11
Cost of debt 4.00% 5.20%
After-tax WACC 6.5% 9.2%
Selected WACC 7.9%